Gail H Cassell

Gail H Cassell, Ph.D.

Bio
Research
Publications

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Efficacy of clarithromycin against Mycoplasma pneumoniae.

Authors: Authors: Cassell GH, Drnec J, Waites KB, Pate MS, Duffy LB, Watson HL, McIntosh JC.
J Antimicrob Chemother 1991-02-01
View full abstract on Pubmed

The effects of three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitro.

Authors: Authors: Talkington DF, Davis JK, Canupp KC, Garrett BK, Waites KB, Huster GA, Cassell GH.
Fertil Steril 1991-01-01
View full abstract on Pubmed

Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease.

Authors: Authors: Miller ST, Hammerschlag MR, Chirgwin K, Rao SP, Roblin P, Gelling M, Stilerman T, Schachter J, Cassell G.
J Pediatr 1991-01-01
View full abstract on Pubmed

Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn mice.

Authors: Authors: Crouse DT, Cassell GH, Waites KB, Foster JM, Cassady G.
Infect Immun 1990-11-01
View full abstract on Pubmed

Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes.

Authors: Authors: Watson HL, Blalock DK, Cassell GH.
Infect Immun 1990-11-01
View full abstract on Pubmed

Differential induction of bone marrow macrophage proliferation by mycoplasmas involves granulocyte-macrophage colony-stimulating factor.

Authors: Authors: Stuart PM, Cassell GH, Woodward JG.
Infect Immun 1990-11-01
View full abstract on Pubmed

Extragenital Mycoplasma hominis infections in adults.

Authors: Authors: McMahon DK, Dummer JS, Pasculle AW, Cassell G.
Am J Med 1990-09-01
View full abstract on Pubmed

Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population.

Authors: Authors: Waites KB, Duffy LB, Crouse DT, Dworsky ME, Strange MJ, Nelson KG, Cassell GH.
Pediatr Infect Dis J 1990-04-01
View full abstract on Pubmed

Ureaplasma and mycoplasma CNS infections in newborn babies.

Authors: Authors: Waites KB, Crouse DT, Cassell GH.
Lancet 1990-03-17
View full abstract on Pubmed

Ureaplasma felinum sp. nov. and Ureaplasma cati sp. nov. isolated from the oral cavities of cats.

Authors: Authors: Harasawa R, Imada Y, Ito M, Koshimizu K, Cassell GH, Barile MF.
Int J Syst Bacteriol 1990-01-01
View full abstract on Pubmed